Clinical Trials · NCT00729326
Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 83
- Start date
- Aug 2008
- Locations
- 1 site, United States
- Primary endpoint
- Change in Time-averaged Glucose During a 24 Hour Period